1. Home
  2. AIV vs CGEM Comparison

AIV vs CGEM Comparison

Compare AIV & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$5.79

Market Cap

837.1M

Sector

Real Estate

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$13.65

Market Cap

780.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIV
CGEM
Founded
1975
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
837.1M
780.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AIV
CGEM
Price
$5.79
$13.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$10.00
$28.80
AVG Volume (30 Days)
1.7M
694.4K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
62.59%
N/A
EPS Growth
35.34
N/A
EPS
1.80
N/A
Revenue
$208,679,000.00
N/A
Revenue This Year
$6.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.27
N/A
Revenue Growth
11.60
N/A
52 Week Low
$5.24
$5.68
52 Week High
$9.13
$14.02

Technical Indicators

Market Signals
Indicator
AIV
CGEM
Relative Strength Index (RSI) 48.46 68.03
Support Level $5.79 $11.40
Resistance Level $6.04 $12.55
Average True Range (ATR) 0.09 0.94
MACD -0.01 0.13
Stochastic Oscillator 27.45 96.11

Price Performance

Historical Comparison
AIV
CGEM

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: